Constrain Latent Space for Schizophrenia Classification via Dual Space Mapping Net

Mining potential biomarkers of schizophrenia (SCZ) while performing classification is essential for the research of SCZ. However, most related studies only perform a simple binary classification with high-dimensional neuroimaging features that ignore individual’s unique clinical symptoms. And the biomarkers mined in this way are more susceptible to confounding factors such as demographic factors. To address these questions, we propose a novel end-to-end framework, named Dual Spaces Mapping Net (DSM-Net), to map the neuroimaging features and clinical symptoms to a shared decoupled latent space, so that constrain the latent space into a solution space associated with detailed symptoms of SCZ. Briefly, taking functional connectivity patterns and the Positive and Negative Syndrome Scale (PANSS) scores as input views, DSM-Net maps the inputs to a shared decoupled latent space which is more discriminative. Besides, with an invertible space mapping sub-network, DSM-Net transforms multi-view learning into multi-task learning and provides regression of PANSS scores as an extra benefit. We evaluate the proposed DSM-Net with multi-site data of SCZ in the leave-one-site-out cross validation setting and experimental results illustrate the effectiveness of DSM-Net in classification, regression performance, and unearthing neuroimaging biomarkers with individual specificity, population commonality and less effect of confusions.

[1]  Raquel Urtasun,et al.  The Reversible Residual Network: Backpropagation Without Storing Activations , 2017, NIPS.

[2]  M S Buchsbaum,et al.  The frontal lobes, basal ganglia, and temporal lobes as sites for schizophrenia. , 1990, Schizophrenia bulletin.

[3]  Marisa O. Hollinshead,et al.  The organization of the human cerebral cortex estimated by intrinsic functional connectivity. , 2011, Journal of neurophysiology.

[4]  Yu Zhang,et al.  The Human Brainnetome Atlas: A New Brain Atlas Based on Connectional Architecture , 2016, Cerebral cortex.

[5]  Tianzi Jiang,et al.  BRANT: A Versatile and Extendable Resting-State fMRI Toolkit , 2018, Front. Neuroinform..

[6]  S. Kay,et al.  The positive and negative syndrome scale (PANSS) for schizophrenia. , 1987, Schizophrenia bulletin.

[7]  Daniel R. Weinberger,et al.  Schizophrenia and the frontal lobe , 1988, Trends in Neurosciences.

[8]  Jing Sui,et al.  Discriminating schizophrenia using recurrent neural network applied on time courses of multi-site FMRI data , 2019, EBioMedicine.

[9]  Hilleke E. Hulshoff Pol,et al.  Classification of schizophrenia patients and healthy controls from structural MRI scans in two large independent samples , 2012, NeuroImage.

[10]  M. Gill,et al.  Detecting schizophrenia at the level of the individual: relative diagnostic value of whole-brain images, connectome-wide functional connectivity and graph-based metrics , 2019, Psychological Medicine.

[11]  Juntang Zhuang,et al.  Invertible Network for Classification and Biomarker Selection for ASD , 2019, MICCAI.

[12]  Edward T. Bullmore,et al.  Fledgling pathoconnectomics of psychiatric disorders , 2013, Trends in Cognitive Sciences.

[13]  Tao Xiang,et al.  Scalable and Effective Deep CCA via Soft Decorrelation , 2017, 2018 IEEE/CVF Conference on Computer Vision and Pattern Recognition.